Stock Events

Alnylam Pharmaceuticals (DUL.F) Q1 2024 Earnings

DUL.F +0.92%
15FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.02
-0.8
0.42
1.64

Details

Expected EPS
-1.1695824
Actual EPS
-0.7147448
Surprise EPS
0.45
Surprise Percent
+38.89%

Description

Alnylam Pharmaceuticals (DUL.F) has reported earnings of -0.7147448 per share for Q1 2024.

0 Comments

Share your thoughts